Agenda Topics- Circulating RNAs as a Potential Biomarker Class (Small RNAs such as microRNAs are an Attractive Biomarker Class)
- Circulating Tumor Cells (CTCs): Methodologies for Isolation and Interrogation
- Head-to-Head Comparison of CTCs with ctDNA as Circulating Biomarkers
- Circulating Tumor DNA (ctDNA): Potential for Monitoring Disease Progression in Oncology
- Circulating-Free DNA (cfDNA) as a Cancer Biomarker for Correctly Deploying Targeted Therapeutics and Enabling Personalized Medicine
- Digital PCR Applications for Circulating Biomarker Interrogation
- Methodologies for Isolating and Characterizing Extracellular Nucleic Acids (cfDNA, Extracellular RNA)
- Tools and Technologies for Monitoring Extracellular Nucleic Acids in Biological Fluids
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager jeff@selectbioconferences.com +1-510-857-4865
|
Confirmed Speakers to dateTania Konry, Assistant Professor, Department of Pharmaceutical Sciences, Northeastern University Martin Beaulieu, Director, Regulus Therapeutics Inc Farideh Bischoff, Executive Director, Silicon Biosystems Inc Cesar Castro, Director – Cancer Program, Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School Saumya Das, Assistant Professor in Medicine, Beth Israel Deaconess Medical Center and Mass General Hospital Brian Dougherty, Executive Director, Translational Genomics, Oncology IMED, AstraZeneca R&D Z Fan, Professor, University of Florida Tony Godfrey, Associate Chair – Research, Department of Surgery, Boston University Medical Center Kenneth Kotz, Assistant in Bioengineering & Instructor, Massachusetts General Hospital/Harvard Medical School Pavan Kumar, Senior Scientist, Eisai Inc Mike Makrigiorgos, Professor of Radiation Oncology, Dana Farber Cancer Institute and Harvard Medical School Abhijit Patel, Associate Professor, Yale University School of Medicine Meeta Patnaik, CMO, AXON Dx Kristin Ciriello Pothier, Partner & Managing Director/Life Sciences Leader, Ernst and Young LLP Lidong Qin, Professor and CPRIT Scholar, Houston Methodist Research Institute Katherine Richardson, Vice President, Research & Development, Transgenomic, Inc. Jeff Stoll, Vice President, Life Sciences, Ernst & Young LLP Shannon Stott, Assistant Professor, Massachusetts General Hospital & Harvard Medical School Alexander Wolf, Scientist, QIAGEN Theresa Zhang, Vice President, Research Services, Personal Genome Diagnostics Weian Zhao, Associate Professor, Department of Biomedical Engineering, University of California-Irvine
|